Bacillus Calmette-Guérin as adjuvant platform enhances immunogenicity of conserved epitopes from structural proteins of SARS-CoV-2 - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Utilizing Bacillus Calmette-Guérin as an Adjuvant to Boost the Immunogenic Response to Conserved Epitopes from SARS-CoV-2 Structural Proteins

  • By

  • Ana de Souza Santos

  • Leonardo Pereira de Araújo

  • Diego Jose Belato Orts

  • Hernan Hermes Monteiro da Costa

  • Kely Catarine Matteucci

  • Evandro Neves Silva

  • Karen Cristina Oliveira

  • Giovane Galdino

  • Carlos Roberto Prudencio

  • Patrícia Paiva Corsetti

  • Leonardo Augusto de Almeida

  • July 16, 2026

Share

Original Source(s)

Bacillus Calmette-Guérin as adjuvant platform enhances immunogenicity of conserved epitopes from structural proteins of SARS-CoV-2

  • by Ana de Souza Santos, Leonardo Pereira de Araújo, Diego Jose Belato Orts, Hernan Hermes Monteiro da Costa, Kely Catarine Matteucci, Evandro Neves Silva, Karen Cristina Oliveira, Giovane Galdino, Carlos Roberto Prudencio, Patrícia Paiva Corsetti, Leonardo Augusto de Almeida

  • July 16, 2026

Related Content

Error in Figure

  • July 16, 2026

From Solution Traps to Solution Patchwork: Easing Tensions in Designing Digital Health in the Global Context

Toll-like receptors in infectious myocarditis: pathogen-specific recognition, spatiotemporal dynamic regulation and clinical translation